Setup, so nobody has to ask: SURMOUNT-1 · tirzepatide. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
Top voted questions
Highest-scoring questions on the site.
The case in front of me: 10 mg · liraglutide. I want the working, not the result — I need to be able to redo it with different numbers. I care about the precision as…
Details up front: ferritin · liraglutide. I want to know whether this is a real physical effect or an artefact of how it is measured. What prompted the question is an…
The lot number on the vial matches the certificate, which at least rules out the easy problem. I keep seeing this stated as a fact with no explanation attached, and…
The specifics, since they change the answer: SELECT · 2 mg. I want to understand what this actually establishes, as opposed to what it is being used to imply. My…
Numbers first: a GLP-1 receptor agonist · 5 mg. This should be a straightforward calculation and I keep getting two different answers. The numbers are arbitrary; the…
What I am working with: dizziness · semaglutide · SELECT. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at…
The pharmacy is accredited and I have verified that on the accreditor register. I am trying to do this correctly the first time rather than learn it by getting it…
For reference: South Africa · twenty-eight days. I think I have a problem. I am not yet sure whether it is a real problem or a measurement artefact. I want to know…
What I have: racemisation · orforglipron · 2–8 °C. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a boring…
Setup, so nobody has to ask: retatrutide · sampling plan. I have read the primary source rather than the summary, which has left me with more questions. I understand…
Numbers first: a GLP-1 receptor agonist · 1.7 mg. This should be a straightforward calculation and I keep getting two different answers. The numbers are arbitrary;…
Setup, so nobody has to ask: WXT · a GLP-1 receptor agonist. This is asserted often enough that I assumed it was established, and then I went looking for the source.…
The lot number on the vial matches the certificate, which at least rules out the easy problem. Everything I have found on this is either a forum aside or a product…
What I am working with: liraglutide · cagrilintide. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the arguments for each…
Concretely: batch certificate · BCH. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me which work…
The particulars: tirzepatide · 10 mg/mL · four weeks. Somebody stated this to me confidently and I would like to check it before repeating it. I would accept a…
Details up front: mazdutide · 4 mg/mL. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum viable…
Setup, so nobody has to ask: headache · cagrilintide. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me suspicious. My…
I am comparing three suppliers on documentation rather than on price. I would like to know the limits of what can be inferred from this. What I am trying to avoid is…
I have both a purity figure and a content figure, which is why the discrepancy is visible. I would like the mechanism, because I want to be able to reason about the…
Concretely: ecnoglutide · 8 mg/mL. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow the plan I write down, so…
The specifics, since they change the answer: Suzhou · Australia. The figures are clear enough; the question is what they mean and what they do not. I can supply the…
Setup, so nobody has to ask: 97.1% · Medutest · 96.8%. I noticed this today and I have not touched anything since, in case the state is diagnostic. I have not…